作为一种抗菌药物管理策略的碳烯降级:叙事性审查
Adriana Gardner1,2, Paul Nieberg3, George Sakoulas4,5
1Department of Pharmacy, Huntington Health, Pasadena, CA, USA.
JAC-antimicrobial resistance
|March 10, 2025
概括
降低卡巴胺抗生素的升级,在抗菌药物管理计划 (ASP) 中的一种策略,可以减少抗生素的使用,而不会对患者的治疗结果产生负面影响. 仔细选择患者是成功降低抗生素升级的关键.
科学领域:
- 传染性疾病 传染性疾病
- 抗微生物耐药性 抗微生物耐药性
- 临床药房 临床药房
背景情况:
- 碳烯的上升规定了燃料,碳烯耐药的病原体.
- 抗生素管理计划 (ASP) 旨在减少不必要的抗生素暴露.
- 临床医生因为担心患者的结果而犹不决.
研究的目的:
- 为了描述碳烯缓和升级策略.
- 评估与碳烯减缓相关的患者结果.
主要方法:
- 在PubMed. 的文献搜索.
- 选了228篇文章,包括15项关于碳胺降级到非碳胺替代品的研究.
- 包括超过5000名非危急病患者,具有常见感染的免疫能力的成年人.
主要成果:
- 在12/15研究中,碳烯胺降级使碳烯胺使用量减少了2-5天.
- 降级并没有与增加临床失败或死亡率有关.
- 报告的患者特征不一致,可能会导致结果偏见.
结论:
- 碳胺降级是一种有前途的ASP策略.
- 仔细的患者选择对于成功的抗生素降级至关重要.
- 需要进一步的高质量研究来证实对临床结果的影响.
相关概念视频
Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


